Baseline Clearance of Infliximab is Associated with Requirement for Colectomy in Patients with Acute Severe Ulcerative Colitis

BACKGROUND & AIMS: Hospitalized patients with acute severe ulcerative colitis (ASUC) often require surgery. Although the tumor necrosis factor antagonist infliximab is an effective salvage therapy to prevent colectomy in patients with ASUC, optimal dosing is unclear. Calculated infliximab cleara...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Gastroenterol Hepatol
Main Authors: Battat, Robert, Hemperly, Amy, Truong, Stephanie, Whitmire, Natalie, Boland, Brigid S., Dulai, Parambir S, Holmer, Ariela K, Nguyen, Nghia H, Singh, Siddharth, Casteele, Niels Vande, Sandborn, William J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606215/
https://ncbi.nlm.nih.gov/pubmed/32348905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.03.072
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados